Immutep
IMMP
#8109
Rank
C$0.36 B
Marketcap
C$2.49
Share price
1.12%
Change (1 day)
-19.35%
Change (1 year)

P/E ratio for Immutep (IMMP)

P/E ratio as of December 2025 (TTM): -22.1

According to Immutep's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -22.089. At the end of 2024 the company had a P/E ratio of -8.46.

P/E ratio history for Immutep from 2016 to 2018

PE ratio at the end of each year

Year P/E ratio Change
2024-8.4618.87%
2023-7.12-7.44%
2022-7.69-27.66%
2021-10.6118.58%
2020-4.869.65%
2019-4.43-34.52%
2018-6.774.94%
2017-6.45311.69%
2016-1.57-51.5%
2015-3.23-16.77%
2014-3.88-41.24%
2013-6.61-17.71%
2012-8.03

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Illumina
ILMN
28.9-230.61%๐Ÿ‡บ๐Ÿ‡ธ USA
HTG Molecular Diagnostics
HTGM
-0.0169-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
FibroGen
FGEN
0.1574-100.71%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.